集体诉讼案件信息 - 罗森律师事务所提醒在2025年5月7日至2025年8月5日期间购买LifeMD公司证券的投资者注意2025年10月27日的重要首席原告截止日期 [1] - 投资者若在上述期间购买LifeMD证券，可能有权通过风险代理收费安排获得补偿，无需支付任何自付费用 [2] - 投资者可通过访问指定网站或联系菲利普·金律师以加入该集体诉讼 [3][6] 诉讼指控内容 - 指控被告在整个集体诉讼期间做出了重大虚假和/或误导性陈述，和/或未能披露相关信息 [5] - 指控被告在提高LifeMD公司2025年业绩指引时存在鲁莽行为，未恰当核算其RexMD业务部门不断增长的客户获取成本，以及与销售Wegovy和Zepbound等肥胖症治疗药物相关的客户获取成本 [5] - 指控被告关于LifeMD业务、运营和前景的陈述在所有相关时间均存在重大虚假和误导性和/或缺乏合理依据 [5] 律师事务所背景 - 罗森律师事务所专注于证券集体诉讼和股东衍生诉讼，在全球范围内代表投资者 [4] - 该律师事务所曾达成当时针对中国公司的史上最大证券集体诉讼和解，并在2017年被ISS证券集体诉讼服务评为和解数量第一，自2013年以来每年排名前四 [4] - 该律师事务所已为投资者追回数亿美元，仅在2019年就为投资者确保了超过4.38亿美元 [4]

诉讼核心指控 - 指控LifeMD公司在2025年5月7日至8月5日期间做出 materially false and/or misleading statements [3][7] - 指控公司 materially overstated LifeMD's competitive position [3] - 指控公司在提高2025年业绩指引时行为 reckless，未恰当核算RexMD业务部门不断上升的客户获取成本 [3] - 指控公司未恰当核算与销售肥胖症治疗药物相关的客户获取成本，包括Wegovy和Zepbound [3] - 指控结果导致公司关于其业务、运营和前景的陈述存在 materially false and misleading 和/或缺乏合理依据 [3] 诉讼程序信息 - 集体诉讼已在纽约东区联邦地区院 filed on behalf of investors who purchased LifeMD securities between May 7, 2025 and August 5, 2025 [7] - 投资者申请成为首席原告的截止日期为2025年10月27日 [7]

诉讼案件基本信息 - 美国罗森律师事务所提醒在2025年5月7日至2025年8月5日期间购买LifeMD公司（NASDAQ: LFMD）证券的投资者，关于一项证券集体诉讼的重要牵头原告截止日期为2025年10月27日 [1] - 投资者可能有权通过风险代理收费安排获得补偿，无需支付任何自付费用或成本 [2] - 一项针对LifeMD的集体诉讼已被提起，投资者可通过指定网站、电话或电子邮件加入该诉讼 [3][6] 诉讼指控内容 - 指控被告在诉讼期间做出了重大虚假和/或误导性陈述，和/或未能披露相关信息 [5] - 具体指控包括：被告 materially overstated（ materially overstated）了LifeMD的竞争地位 [5] - 被告在提高LifeMD的2025年业绩指引时是reckless（ reckless）的，因其未恰当核算RexMD业务部门不断上升的客户获取成本，以及与销售Wegovy和Zepbound等肥胖症治疗药物相关的客户获取成本 [5] - 因此，被告关于LifeMD业务、运营和前景的陈述在所有相关时间点均存在重大虚假误导和/或缺乏合理依据 [5] 律师事务所背景 - 罗森律师事务所专注于证券集体诉讼和股东衍生诉讼，在全球代表投资者 [4] - 该所曾达成针对中国公司的史上最大证券集体诉讼和解案 [4] - 根据ISS Securities Class Action Services数据，该所在2017年证券集体诉讼和解数量排名第一，自2013年以来每年均排名前四 [4] - 该所为投资者追回数亿美元，仅在2019年就为投资者获得超过4.38亿美元 [4]

, /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of LifeMD, Inc. (NASDAQ: LFMD). CONTACT: The Gross Law Firm 15 West 38th Street, 12th floor New York, NY, 10018 Email: [email protected] Phone: (646) 453-8903 CLASS PERIOD: May 7, 2025 to August 5, 2025 ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and/or misleading statements and/or failed to disclose that: (1) defendants materially overstated LifeMD's competitive positio ...

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding In LifeMD To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in LifeMD between May 7, 2025 and August 5, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK, Oct. 05, 2025 (GLOBE NEWSWIRE) -- Faru ...

, /PRNewswire/ -- Berger Montague PC, national plaintiffs' law firm, announces a class action lawsuit against LifeMD, Inc. (NASDAQ: LFMD) ("LifeMD" or the "Company") on behalf of investors who purchased or acquired shares during the period from May 7, 2025 through August 5, 2025 (the "Class Period"). Investor Deadline: Investors who purchased or acquired LifeMD securities during the Class Period may, no later than October 27, 2025, seek to be appointed as a lead plaintiff representative of the class. To le ...

NEW YORK, Oct. 03, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of LifeMD, Inc. (NASDAQ: LFMD) between May 7, 2025 and August 5, 2025, both dates inclusive (the “Class Period”), of the important October 27, 2025 lead plaintiff deadline in the securities class action first filed by the Firm. SO WHAT: If you purchased LifeMD securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or c ...

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In LifeMD (LFMD) To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in LifeMD between May 7, 2025 and August 5, 2025 and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or Marion Passmore directly at (212) 355-4648. Click here to participate in the action. NEW YORK, Oct. 03, 2025 (GLOBE NEWSWIRE) -- What’s Happening: Bragar E ...

If you suffered losses in LifeMD between May 7, 2025 and August 5, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330Â (Ext. 1310). Accessibility StatementSkip Navigation Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In LifeMD To Contact Him Directly To Discuss Their Options [You may also click here for additional information] NEW YORK, Oct. 2, 2025 /PRNewswire/ ...

DEADLINE: October 27, 2025 CASE DETAILS: According to the Complaint, the Company made false and misleading statements to the market. LifeMD raised its guidance for fiscal year 2025 while ignoring important factors like customer acquisition costs. Based on these facts, LifeMD's public statements were false and materially misleading throughout the class period. If you are a shareholder who suffered a loss, contact us to participate . NEXT STEPS FOR SHAREHOLDERS : Once you register as a shareholder who purchas ...